Fulgent Genetics
FLGT
15 hedge funds and large institutions have $24.4M invested in Fulgent Genetics in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.36M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.55M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$3.41M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.38M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$1.15M |
Top Sellers
FLGT Hedge Fund Activity: Q3 2016 in Review
15 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2016, worth a combined $24.4M.
Buyers outnumbered sellers: 15 funds opened new FLGT positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $7.36M.
- 15 institutional investors held Fulgent Genetics (FLGT) as of Q3 2016, up from 0 in Q2 2016.
- Funds reported $24.4M of Fulgent Genetics stock for Q3 2016.
- 15 funds opened new Fulgent Genetics positions in Q3 2016 and 0 closed out, a net change of +15 holders.
- The largest Fulgent Genetics buyer in Q3 2016 was Cormorant Asset Management, an estimated $7.36M added.
Based on aggregated 13F filings for Q3 2016.